EMN - Eastman Chemical Co Stock Price, Fair Value and News

95.52USD-0.61 (-0.63%)Delayed

Market Summary

USD95.52-0.61

Delayed

-0.63%

EMN Stock Price

View Fullscreen

EMN RSI Chart

EMN Valuation

Market Cap

11.2B

Price/Earnings (Trailing)

12.15

Price/Sales (Trailing)

1.23

EV/EBITDA

10.93

Price/Free Cashflow

21.57

EMN Price/Sales (Trailing)

EMN Profitability

EBT Margin

12.15%

Return on Equity

16.49%

Return on Assets

6.27%

Free Cashflow Yield

4.64%

EMN Fundamentals

EMN Revenue

Revenue (TTM)

9.1B

Rev. Growth (Yr)

-4.23%

Rev. Growth (Qtr)

4.67%

EMN Earnings

Earnings (TTM)

925.0M

Earnings Growth (Yr)

23.13%

Earnings Growth (Qtr)

-46.77%

Breaking Down EMN Revenue

Last 7 days

-0.9%

Last 30 days

-4.1%

Last 90 days

12.5%

Trailing 12 Months

18.6%

How does EMN drawdown profile look like?

EMN Financial Health

Current Ratio

1.39

Debt/Equity

0.77

Debt/Cashflow

0.31

EMN Investor Care

Buy Backs (1Y)

1.26%

Diluted EPS (TTM)

7.76

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	9.1B	0	0	0
2023	10.3B	9.8B	9.4B	9.2B
2022	10.8B	10.9B	10.9B	10.6B
2021	8.6B	9.4B	10.0B	10.5B
2020	9.1B	8.7B	8.5B	8.5B
2019	9.9B	9.7B	9.4B	9.3B
2018	9.9B	10.1B	10.1B	10.2B
2017	9.1B	9.2B	9.4B	9.5B
2016	9.4B	9.2B	9.0B	9.0B
2015	9.7B	9.7B	9.8B	9.6B
2014	9.3B	9.4B	9.4B	9.5B
2013	8.6B	9.2B	9.3B	9.3B
2012	7.2B	7.2B	7.7B	8.1B
2011	6.2B	6.6B	6.9B	7.2B
2010	4.6B	4.9B	5.1B	5.8B
2009	5.3B	4.8B	4.3B	4.4B
2008	0	6.5B	6.2B	5.9B
2007	0	0	0	6.8B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Eastman Chemical Co

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 06, 2024	holt adrian james	sold	-415,519	87.7548	-4,735	svp, chf hr ofcr
Mar 06, 2024	holt adrian james	acquired	250,116	72.92	3,430	svp, chf hr ofcr
Mar 01, 2024	lich brad a	acquired	-	-	11,922	evp & cco
Mar 01, 2024	costa mark j	sold	-1,051,200	87.6	-12,000	ceo & board chair
Mar 01, 2024	lich brad a	sold (taxes)	-408,626	87.09	-4,692	evp & cco
Feb 26, 2024	stewart michelle renee	sold (taxes)	-12,029	86.54	-139	controller & cao
Feb 26, 2024	stewart michelle renee	acquired	-	-	499	controller & cao
Feb 14, 2024	walker kellye l.	sold (taxes)	-143,053	82.12	-1,742	evp, clo & corp. secretary
Feb 14, 2024	walker kellye l.	sold (taxes)	-141,657	82.12	-1,725	evp, clo & corp. secretary
Feb 14, 2024	killian christopher moore	acquired	-	-	2,174	svp & cto

Which funds bought or sold EMN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Bogart Wealth, LLC	new	-	1,285	1,285	-%
Apr 25, 2024	NATIXIS ADVISORS, L.P.	added	0.47	3,365,000	31,165,000	0.07%
Apr 25, 2024	Ulland Investment Advisors, LLC	unchanged	-	3,000	25,000	0.02%
Apr 25, 2024	Telos Capital Management, Inc.	unchanged	-	24,814	239,125	0.03%
Apr 25, 2024	Allworth Financial LP	added	9.62	28,744	157,546	-%
Apr 25, 2024	Checchi Capital Advisers, LLC	reduced	-1.74	25,895	294,547	0.02%
Apr 25, 2024	SIMPLEX TRADING, LLC	reduced	-6.91	37,000	975,000	-%
Apr 25, 2024	Chicago Partners Investment Group LLC	new	-	219,583	219,583	0.01%
Apr 25, 2024	Zurcher Kantonalbank (Zurich Cantonalbank)	added	2.99	757,973	5,839,720	0.02%
Apr 25, 2024	PATRICK M SWEENEY & ASSOCIATES, INC	added	0.06	34,704	332,820	0.27%

Are Funds Buying or Selling EMN?

Are funds buying EMN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own EMN

No. of Funds

Unveiling Eastman Chemical Co's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	12.52%	14,839,678	SC 13G/A
Jan 26, 2024	blackrock inc.	7.1%	8,383,444	SC 13G/A
Jan 04, 2024	jpmorgan chase & co	4.6%	5,549,362	SC 13G/A
Feb 13, 2023	capital world investors	0.0%	0	SC 13G/A
Feb 09, 2023	vanguard group inc	12.50%	14,994,249	SC 13G/A
Jan 31, 2023	blackrock inc.	7.2%	8,615,723	SC 13G/A
Jan 20, 2023	jpmorgan chase & co	8.2%	9,862,144	SC 13G/A
Feb 11, 2022	capital world investors	6.3%	8,452,732	SC 13G/A
Feb 09, 2022	vanguard group inc	11.92%	16,026,862	SC 13G/A
Feb 01, 2022	blackrock inc.	6.6%	8,855,207	SC 13G/A

Recent SEC filings of Eastman Chemical Co

View All Filings

Date Filed	Form Type	Document
Apr 26, 2024	10-Q	Quarterly Report
Apr 25, 2024	8-K	Current Report
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading
Apr 09, 2024	4	Insider Trading

Peers (Alternatives to Eastman Chemical Co)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
APD	52.5B	12.4B	-2.90%	-18.99%	22.47	4.23	-3.54%	3.06%
DOW	40.3B	43.5B	-1.48%	7.07%	31.2	0.93	-18.61%	-56.65%
CE	16.8B	10.9B	-8.98%	50.33%	8.58	1.54	13.10%	3.48%
AVTR	16.3B	6.9B	-6.41%	27.75%	62.54	2.37	-6.48%	-57.90%
ALB	13.7B	9.6B	-9.27%	-37.17%	8.72	1.43	31.38%	-41.50%
EMN	11.2B	9.1B	-4.08%	18.57%	12.15	1.23	-11.38%	33.67%
MID-CAP
CBT	5.2B	3.9B	1.80%	32.34%	11.66	1.32	-9.12%	26.64%
BCPC	4.5B	922.4M	-9.82%	10.29%	41.41	4.87	-2.11%	3.01%
AVNT	3.9B	3.1B	0.61%	14.10%	51.82	1.25	-7.48%	-89.19%
ARCH	3.0B	3.0B	1.08%	35.48%	9.35	1.02	-20.68%	-74.24%
SMALL-CAP
CCF	1.2B	404.0M	0.11%	32.60%	36.59	3	24.06%	-25.72%
ASIX	693.9M	1.5B	-5.66%	-29.87%	12.7	0.45	-21.18%	-60.55%
CMT	174.6M	357.7M	4.15%	4.83%	8.59	0.49	-5.20%	66.55%
AREC	121.3M	16.7M	6.90%	34.78%	10.95	7.25	-57.58%	866.09%
AMRS	3.7M	-	-80.00%	-99.58%	-0.01	0.01	-	-

Eastman Chemical Co News

Latest updates

Eastman Chemical Co Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	4.7%	2,310	2,207	2,267	2,324	2,412	2,373	2,709	2,784	2,714	2,694	2,720	2,653	2,409	2,186	2,122	1,924	2,241	2,205	2,325	2,363	2,380
Gross Profit	14.7%	532	464	484	584	529	376	541	670	550	559	662	681	598	526	501	371	577	497	574	589	574
S&GA Expenses	0%	191	191	160	185	191	172	173	185	196	208	201	202	184	174	165	155	160	176	163	165	187
R&D Expenses	3.5%	59.00	57.00	60.00	60.00	62.00	64.00	68.00	67.00	65.00	67.00	66.00	63.00	58.00	57.00	56.00	52.00	61.00	60.00	59.00	57.00	58.00
EBITDA Margin	1.8%	0.15*	0.15*	0.10*	0.11*	0.12*	0.12*	0.16*	0.17*	0.12*	0.14*	0.09*	0.09*	0.11*	0.11*	0.10*	0.12*	0.15*	0.14*	0.14*	0.16*	0.16*
Interest Expenses	5.8%	-49.00	-52.00	-57.00	-54.00	-52.00	-48.00	-43.00	-45.00	-46.00	-48.00	-49.00	-51.00	-50.00	-51.00	-52.00	-55.00	-52.00	-53.00	-54.00	-55.00	-56.00
Income Taxes	-57.0%	49.00	114	20.00	-3.00	60.00	26.00	-20.00	124	51.00	149	-33.00	37.00	62.00	-9.00	25.00	-31.00	56.00	-18.00	46.00	57.00	55.00
Earnings Before Taxes	-49.6%	214	425	199	269	194	28.00	281	381	287	529	321	-107	339	25.00	190	-1.00	316	9.00	313	316	264
EBT Margin	3.0%	0.12*	0.12*	0.07*	0.08*	0.09*	0.09*	0.14*	0.14*	0.10*	0.10*	0.06*	0.05*	0.06*	0.06*	0.06*	0.07*	0.10*	0.10*	0.10*	0.11*	0.12*
Net Income	-46.8%	165	310	178	272	134	1.00	301	256	235	378	351	-146	274	32.00	161	27.00	258	26.00	266	258	209
Net Income Margin	4.6%	0.10*	0.10*	0.06*	0.07*	0.07*	0.07*	0.11*	0.11*	0.08*	0.08*	0.05*	0.03*	0.06*	0.06*	0.06*	0.07*	0.09*	0.08*	0.08*	0.09*	0.10*
Free Cashflow	-173.6%	-201	273	278	171	-176	254	95.00	110	-95.00	190	430	319	125	301	360	339	72.00	554	306	330	-111

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	0.8%	14,748	14,633	14,594	14,771	14,983	14,667	14,985	14,875	15,806	15,519	16,259	16,098	16,195	16,083	16,009	15,973	16,465	16,008	16,137	16,256	16,361
Current Assets	4.5%	3,638	3,481	3,567	3,671	3,973	3,778	4,105	4,003	4,929	4,646	4,875	4,738	3,797	3,541	3,534	3,526	3,851	3,321	3,440	3,516	3,551
Cash Equivalents	-8.9%	499	548	439	410	599	493	461	456	487	459	717	609	540	564	650	704	680	204	207	186	195
Inventory	5.1%	1,769	1,683	1,721	1,960	1,944	1,894	1,975	1,826	1,671	1,504	1,630	1,501	1,505	1,379	1,338	1,419	1,659	1,662	1,695	1,730	1,704
Net PPE	-0.2%	5,535	5,548	5,426	5,402	5,258	5,160	4,982	4,959	4,997	4,996	5,172	5,181	5,466	5,549	5,489	5,478	5,498	5,571	5,534	5,550	5,576
Goodwill	-0.1%	3,644	3,646	3,643	3,697	3,703	3,664	3,644	3,663	3,665	3,641	4,044	4,053	4,446	4,465	4,443	4,425	4,417	4,431	4,464	4,481	4,477
Liabilities	0.4%	9,140	9,103	9,170	9,419	9,721	9,431	9,518	9,468	9,829	9,731	10,052	10,070	9,876	9,975	9,853	9,875	10,273	9,976	10,040	10,310	10,442
Current Liabilities	1.6%	2,618	2,576	2,615	2,787	2,971	3,251	3,207	3,148	3,136	2,971	3,113	2,295	2,016	2,038	1,789	1,878	2,315	1,789	2,080	2,226	2,352
Short Term Borrowings	36.8%	740	541	640	844	1,014	1,126	1,086	979	984	747	1,046	325	324	349	370	702	895	171	642	731	862
Long Term Debt	0.8%	4,340	4,305	4,580	4,593	4,636	4,025	3,979	4,012	4,379	4,412	4,442	5,223	5,200	5,269	5,495	5,431	5,399	5,611	5,567	5,624	5,602
LT Debt, Non Current	-100.0%	-	4,305	4,580	4,593	4,636	4,025	3,979	4,012	4,379	4,412	4,442	5,223	5,200	5,269	5,495	5,431	5,399	5,611	5,567	5,624	5,602
Shareholder's Equity	2.7%	5,608	5,458	5,352	5,352	5,262	5,153	5,467	5,407	5,977	5,788	6,207	6,028	6,319	6,108	6,156	6,098	6,192	6,032	6,097	5,946	5,919
Retained Earnings	0.7%	9,559	9,490	9,274	9,190	9,013	8,973	9,065	8,857	8,694	8,557	8,278	8,020	8,260	8,080	8,142	8,071	8,133	7,965	8,029	7,848	7,675
Additional Paid-In Capital	0.8%	2,388	2,368	2,352	2,342	2,325	2,315	2,301	2,179	2,262	2,187	2,275	2,255	2,219	2,174	2,134	2,117	2,109	2,105	2,092	2,079	2,060
Accumulated Depreciation	1.1%	8,116	8,026	7,956	7,959	7,895	7,782	7,663	7,784	7,756	7,684	7,966	7,898	8,061	7,982	7,843	7,697	7,584	7,510	7,364	7,298	7,220
Shares Outstanding	0.3%	118	117	119	119	119	119	120	123	129	129	134	136	136	136	135	135	136	136	136	137	139
Minority Interest	-2.8%	70.00	72.00	72.00	71.00	74.00	83.00	83.00	84.00	84.00	84.00	87.00	84.00	86.00	85.00	81.00	77.00	75.00	74.00	77.00	77.00	76.00
Float	-100.0%	-	9,763	-	-	-	10,607	-	-	-	14,993	-	-	-	9,409	-	-	-	-	-	10,531	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-103.5%	-16.00	452	514	410	-2.00	457	256	245	17.00	430	547	426	216	406	442	436	171	671	416	422	-5.00
Cashflow From Investing	-172.2%	-179	248	-182	-246	-252	-206	-158	873	-117	418	-170	-178	-99.00	-112	-81.00	-100	-101	-120	-141	-94.00	-125
Cashflow From Financing	125.0%	148	-593	-299	-353	357	-223	-88.00	-1,139	129	-1,106	-269	-178	-137	-382	-416	-314	408	-556	-250	-339	102
Dividend Payments	1.1%	95.00	94.00	94.00	94.00	94.00	91.00	94.00	98.00	98.00	93.00	94.00	94.00	94.00	89.00	90.00	89.00	90.00	85.00	85.00	86.00	87.00

EMN Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF EARNINGS, COMPREHENSIVE INCOME AND RETAINED EARNINGS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Sales	$ 9,210	$ 10,580	$ 10,476
Cost of sales	7,149	8,443	7,976
Gross profit	2,061	2,137	2,500
Selling, general and administrative expenses	727	726	795
Research and development expenses	239	264	254
Asset impairments and restructuring charges, net	37	52	47
Other components of post-employment (benefit) cost, net	41	(101)	(412)
Other (income) charges, net	38	(6)	(17)
Net (gain) loss on divested businesses	(323)	43	552
Earnings before interest and taxes	1,302	1,159	1,281
Net interest expense	215	182	198
Early debt extinguishment costs	0	0	1
Earnings before income taxes	1,087	977	1,082
Provision for income taxes	191	181	215
Net earnings	896	796	867
Less: Net earnings attributable to noncontrolling interest	2	3	10
Net earnings attributable to Eastman	$ 894	$ 793	$ 857
Basic earnings per share attributable to Eastman
Basic earnings per share attributable to Eastman	$ 7.54	$ 6.42	$ 6.35
Diluted earnings per share attributable to Eastman
Diluted earnings per share attributable to Eastman	$ 7.49	$ 6.35	$ 6.25
Comprehensive Income
Net earnings including noncontrolling interest	$ 896	$ 796	$ 867
Other comprehensive income (loss), net of tax:
Change in cumulative translation adjustment	(67)	7	56
Defined benefit pension and other postretirement benefit plans [Abstract]
Amortization of unrecognized prior service credits included in net periodic costs	(21)	(27)	(28)
Derivatives and hedging [Abstract]
Unrealized gain (loss) during period	(27)	53	66
Reclassification adjustment for (gains) losses included in net income, net	1	(56)	(3)
Total other comprehensive income (loss), net of tax	(114)	(23)	91
Comprehensive income including noncontrolling interest	782	773	958
Less: Net earnings attributable to noncontrolling interest	2	3	10
Comprehensive income attributable to Eastman	780	770	948
Retained Earnings
Retained earnings at beginning of period	8,973	8,557	8,080
Net earnings attributable to Eastman	894	793	857
Cash dividends declared	(377)	(377)	(380)
Retained earnings at end of period	$ 9,490	$ 8,973	$ 8,557

EMN Balance Sheet

2023-12-31

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 548	$ 493
Trade receivables, net of allowance for credit losses	826	957
Miscellaneous receivables	328	320
Inventories	1,683	1,894
Other current assets	96	114
Total current assets	3,481	3,778
Properties
Properties and equipment at cost	13,574	12,942
Less: Accumulated depreciation	8,026	7,782
Net properties	5,548	5,160
Goodwill	3,646	3,664
Intangible assets, net of accumulated amortization	1,138	1,210
Other noncurrent assets	820	855
Total assets	14,633	14,667
Current liabilities
Payables and other current liabilities	2,035	2,125
Borrowings due within one year	541	1,126
Total current liabilities	2,576	3,251
Long-term borrowings	4,305	4,025
Deferred income tax liabilities	601	671
Post-employment obligations	667	628
Other long-term liabilities	954	856
Total liabilities	$ 9,103	$ 9,431
Common stock, shares issued (in shares)	222,762,317	222,348,557
Common Stock, Shares Authorized	350,000,000	350,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Stockholders' equity
Common stock ($0.01 par value per share – 350,000,000 shares authorized; shares issued – 222,762,317 and 222,348,557 on December 31, 2023 and 2022, respectively)	$ 2	$ 2
Additional paid-in capital	2,368	2,315
Retained earnings	9,490	8,973
Accumulated other comprehensive loss	(319)	(205)
Total stockholders' equity before treasury stock	$ 11,541	$ 11,085
Treasury stock at cost (in shares)	105,469,354	103,602,488
Less: Treasury stock at cost (105,469,354 and 103,602,488 shares on December 31, 2023 and 2022, respectively)	$ 6,083	$ 5,932
Total Eastman stockholders' equity	5,458	5,153
Noncontrolling interest	72	83
Total equity	5,530	5,236
Total liabilities and stockholders' equity	$ 14,633	$ 14,667

About Eastman Chemical Co

Eastman Chemical Company operates as a specialty materials company in the United States and internationally. The company's Additives & Functional Products segment offers hydrocarbon resins; organic acid-based solutions; amine derivative-based building blocks; metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators; specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; heat transfer and aviation fluids; insoluble sulfur and anti-degradant rubber additives; and performance resins. It serves transportation, personal care, wellness, food, feed, agriculture, building and construction, water treatment, energy, consumables, durables, and electronics markets. Its Advanced Materials segment provides copolyesters, cellulosic biopolymers, cellulose esters, polyvinyl butyral sheets, and window and protective films for value-added end uses in the transportation, durables, electronics, building and construction, medical and pharma, and consumables markets. The company's Chemical Intermediates segment offers methylamines and salts, and higher amines and solvents; Olefin and acetyl derivatives, ethylene, and commodity solvents; and primary non-phthalate and phthalate plasticizers, and niche non-phthalate plasticizers for industrial chemicals and processing, building and construction, health and wellness, and agrochemicals markets. Its Fibers segment provides cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride for use in filtration media primarily cigarette filters; natural and solution dyed acetate yarns for use in consumables, and health and wellness markets; and wet-laid nonwoven media, specialty and engineered papers, and cellulose acetate fibers for transportation, industrial, agriculture and mining, and aerospace markets. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.

CEO	Mr. Mark J. Costa
WEBSITE	eastman.com
INDUSTRY	Chemicals
EMPLOYEES	14500

Eastman Chemical Co Frequently Asked Questions

What is the ticker symbol for Eastman Chemical Co? What does EMN stand for in stocks?

EMN is the stock ticker symbol of Eastman Chemical Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Eastman Chemical Co (EMN)?

As of Fri Apr 26 2024, market cap of Eastman Chemical Co is 11.21 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EMN stock?

You can check EMN's fair value in chart for subscribers.

What is the fair value of EMN stock?

You can check EMN's fair value in chart for subscribers. The fair value of Eastman Chemical Co is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Eastman Chemical Co is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for EMN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Eastman Chemical Co a good stock to buy?

The fair value guage provides a quick view whether EMN is over valued or under valued. Whether Eastman Chemical Co is cheap or expensive depends on the assumptions which impact Eastman Chemical Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EMN.

What is Eastman Chemical Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, EMN's PE ratio (Price to Earnings) is 12.54 and Price to Sales (PS) ratio is 1.22. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EMN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Eastman Chemical Co's stock?

In the past 10 years, Eastman Chemical Co has provided 0.033 (multiply by 100 for percentage) rate of return.